{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:33:39Z","timestamp":1771666419451,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s10875-005-3863-2","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T14:54:09Z","timestamp":1119884049000},"page":"202-208","source":"Crossref","is-referenced-by-count":46,"title":["Evaluation of a New Fluorescent-Enzyme Immuno-Assay for Diagnosis and Follow-up of ANCA-Associated Vasculitis"],"prefix":"10.1007","volume":"25","author":[{"given":"J. G. M. C.","family":"Damoiseaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Slot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vaessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Van Paassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W. Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3863_CR1","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","volume":"337","author":"JC Jennette","year":"1997","unstructured":"Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 337:1512\u20131523, 1997","journal-title":"N Engl J Med"},{"key":"3863_CR2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","volume":"57","author":"J Savige","year":"2000","unstructured":"Savige J, Davies D, Falk RJ, Jennette JC, Wiik A: Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney Int 57:846\u2013862, 2000","journal-title":"Kidney Int"},{"key":"3863_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0953-6205(03)00097-9","volume":"14","author":"A Rutgers","year":"2003","unstructured":"Rutgers A, Heeringa P, Damoiseaux JG, Cohen Tervaert JW: ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 14:287\u2013295, 2003.","journal-title":"Eur J Intern Med"},{"key":"3863_CR4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","volume":"126","author":"PA Merkel","year":"1997","unstructured":"Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126:866\u2013873, 1997","journal-title":"Ann Intern Med"},{"key":"3863_CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(92)90202-M","volume":"93","author":"CG Kallenberg","year":"1992","unstructured":"Kallenberg CG, Mulder AH, Cohen Tervaert JW: Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders. Am J Med 93:675\u2013682, 1992","journal-title":"Am J Med"},{"key":"3863_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"J Savige","year":"1999","unstructured":"Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A: International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 111:507\u2013513, 1999","journal-title":"Am J Clin Pathol"},{"key":"3863_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","volume":"120","author":"J Savige","year":"2003","unstructured":"Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pusey C, Pollock W, Trevisin M, Wiik A, Wong R: Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120:312\u2013318, 2003","journal-title":"Am J Clin Pathol"},{"key":"3863_CR8","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/ndt\/17.12.2077","volume":"17","author":"CA Stegeman","year":"2002","unstructured":"Stegeman CA: Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol Dial Transplant 17:2077\u20132080, 2002","journal-title":"Nephrol Dial Transplant"},{"key":"3863_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","volume":"120","author":"CA Stegeman","year":"1994","unstructured":"Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120:12\u201317, 1994.","journal-title":"Ann Intern Med"},{"key":"3863_CR10","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","volume":"43","author":"MM Boomsma","year":"2000","unstructured":"Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Cohen Tervaert JW: Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study. Arthritis Rheum 43:2025\u20132033, 2000","journal-title":"Arthritis Rheum"},{"key":"3863_CR11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.20234","volume":"51","author":"MC Slot","year":"2004","unstructured":"Slot MC, Cohen Tervaert JW, Boomsma MM, Stegeman CA: Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum 51:269\u2013273, 2004","journal-title":"Arthritis Rheum"},{"key":"3863_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/rheumatology\/keh028","volume":"43","author":"E Csernok","year":"2004","unstructured":"Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL: Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener\u2019s granulomatosis: First results from a multicentre study. Rheumatology (Oxford) 43:174\u2013180, 2004","journal-title":"Rheumatology (Oxford)"},{"key":"3863_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.1987.179","volume":"32","author":"AT Tiebosch","year":"1987","unstructured":"Tiebosch AT, Wolters J, Frederik PF, van der Wiel TW, Zeppenfeldt E, van Breda Vriesman PJ: Epidemiology of idiopathic glomerular disease: A prospective study. Kidney Int 32:112\u2013116, 1987","journal-title":"Kidney Int"},{"key":"3863_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-1759(02)00273-9","volume":"274","author":"MM Boomsma","year":"2003","unstructured":"Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Cohen Tervaert JW: Image analysis: A novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener\u2019s granulomatosis. J Immunol Methods 274:27\u201335, 2003","journal-title":"J Immunol Methods"},{"key":"3863_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192, 1994","journal-title":"Arthritis Rheum"},{"key":"3863_CR16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1990.48","volume":"37","author":"JW Cohen Tervaert","year":"1990","unstructured":"Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AE, Kallenberg CG: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37:799\u2013806, 1990","journal-title":"Kidney Int"},{"key":"3863_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-1759(01)00392-1","volume":"254","author":"MM Boomsma","year":"2001","unstructured":"Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Cohen Tervaert JW: Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J Immunol Methods 254:47\u201358, 2001","journal-title":"J Immunol Methods"},{"key":"3863_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/B:JOCI.0000029115.79266.ae","volume":"24","author":"A Rutgers","year":"2004","unstructured":"Rutgers A, Damoiseaux J, Roozendaal C, Limburg PC, Stegeman CA, Cohen Tervaert JW: ANCA-GBM dot-blot: Evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 24:435\u2013440, 2004","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-005-3863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-005-3863-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-005-3863-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:09:56Z","timestamp":1559275796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-005-3863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["3863"],"URL":"https:\/\/doi.org\/10.1007\/s10875-005-3863-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}